S 366
116th Congress
Senate
Health
Business records
Drug safety, medical device, and laboratory regulation
Government information and archives
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
FLAT Prices Act
Introduced: February 6, 2019
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 6, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Feb 6, 2019
Introduced in Senate
Plain-English summary
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Committees of jurisdiction
1